跳至主要内容
临床试验/NCT02039440
NCT02039440已完成4 期

Neutralizing Antibody Titers 6 Years After the Third Dose of Inactivated Japanese Encephalitis Vaccine and Projected Duration of Protection

Medical University of Vienna2 个研究点 分布在 1 个国家目标入组 67 人开始时间: 2014年2月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
67
试验地点
2
主要终点
Geometric Mean Titer (GMT) for JEV neutralizing antibodies determined by PRNT

研究概览

简要总结

The purpose of this study is to determine whether there are persisting antibodies against Japanese Encephalitis 6 years after the last vaccination with IXIARO(R) and to adapt or confirm mathematical models accordingly.

详细描述

Japanese Encephalitis (JE) is a potentially devastating mosquito-borne viral disease. The JE virus (JEV), a Flavivirus, is endemic to many regions in Asia, and while JE is primarily a pediatric disease in the endemic regions, travelers from non-endemic regions to Asia are usually naïve to the virus and may be at risk for contracting JE at any age.

The present study aims to investigate antibody titers at approximately 6 years after the third dose of JE vaccine (JE-VC), in a cohort of participants from an earlier booster dose trial, to strengthen the statistical model of the duration of protection after the booster.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who received a booster dose of JE-VC in study IC51-311
  • Subjects who are willing to give written informed consent to participate in the trial

排除标准

  • Subjects who received a further dose of any Japanese Encephalitis Vaccine since study IC51-311
  • Severe immunosuppression (as result of medical conditions or medication) since study IC51-311, such as history of radiation therapy or cytostatic therapy
  • simultaneous participation in another clinical study

结局指标

主要结局

Geometric Mean Titer (GMT) for JEV neutralizing antibodies determined by PRNT

时间窗: 1.5 years

次要结局

  • Seroprotection Rate (SPR) defined as rate of subjects with JEV neutralizing antibody titers ≥1:10 in a PRNT(1.5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Herwig Kollaritsch

Ao.Univ.-Prof. Dr.med.univ.

Medical University of Vienna

研究点 (2)

Loading locations...

相似试验

进行中(未招募)
不适用
6-year antibody check after third vaccination against Japanese EncephalitisStudy population: adult volunteers who received a booster dose of JE-VC in prestudy IC51-311, no specific medical condition is investigated, only antibody check.MedDRA version: 16.1Level: LLTClassification code 10023123Term: Japanese encephalitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 16.1Level: LLTClassification code 10069544Term: Japanese encephalitis immunizationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 16.1Level: LLTClassification code 10023120Term: Japanese B viral encephalitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 16.1Level: LLTClassification code 10023122Term: Japanese B virus encephalitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 16.1Level: PTClassification code 10069535Term: Japanese encephalitis immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 16.1Level: LLTClassification code 10023119Term: Japanese B encephalitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 16.1Level: PTClassification code 10014596Term: Encephalitis Japanese BSystem Organ Class: 10021881 - Infections and infestations
EUCTR2013-004366-34-DEMedizinische Universität Wien100
进行中(未招募)
不适用
6-year antibody check after third vaccination against Japanese EncephalitisStudy population: adult volunteers who received a booster dose of JE-VC in prestudy IC51-311, no specific medical condition is investigated, only antibody check.
EUCTR2013-004366-34-ATMedizinische Universität Wien100
已完成
4 期
Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster DoseEncephalitis, Japanese
NCT02514746PATH561
Unknown
4 期
Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang ProvinceJapanese EncephalitisVaccine Preventable DiseaseVaccine Reaction
NCT04817917Zhejiang Provincial Center for Disease Control and Prevention712
已完成
3 期
Study Evaluating Persistence Of Antibody Response Elicited By 13vPnC In Healthy Adults Previously VaccinatedHealthy
NCT01025336Pfizer962